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Abstract Apoptotic protease activating factor-1 (Apaf-1) is an
adaptor molecule essential for caspase-9 activation. Subcellular
analysis of Apaf-1 in NIH-3T3 fibroblasts and the immature
murine B cell lymphoma WEHI-231 indicates that Apaf-1 is
localized in the Golgi apparatus and cytoplasm. Bcl-2 over-
expression in WEHI-231 cells disrupts Apaf-1 localization in
Golgi, causing a perinuclear Apaf-1 redistribution. Bcl-2 over-
expression in NIH-3T3 fibroblasts however does not cause
similar Apaf-1 redistribution, suggesting that cell type factors
are involved in the redistribution process. The ability of Bcl-2 to
modify Apaf-1 subcellular localization is not explained by direct
interaction between Apaf-1 and Bcl-2. These data may help to
clarify the anti-apoptotic Bcl-2 function. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The caspases (cysteinyl aspartate-speci¢c proteinases) are
essential components in apoptosis [1], as con¢rmed by the
profound defects in apoptosis observed in several caspase
knock-out mice. Speci¢cally, cells from caspase-3 or caspase-
9 null mutant mice are resistant to apoptosis induced by a
variety of signals [2]. Speci¢c cofactor molecules are nonethe-
less essential for caspase activation in apoptosis [3]. One of
these adaptors, Apaf-1 (apoptotic protease activating factor-
1), binds caspase-9 via the caspase recruitment domain at its
NH2-terminus, initiating the formation of a supramolecular
complex [4,5]. In vitro oligomerization between Apaf-1 and
caspase-9 occurs in the presence of cytochrome c and
dATP, leading to caspase-9 activation and subsequent proteo-
lytic activation of caspase-3 [4]. The apoptotic process trig-
gered by this initiation complex is negatively regulated by the
anti-apoptotic Bcl-2 family members. The mechanism used by
the anti-apoptotic Bcl-2 family proteins is to block release of
proteins normally con¢ned to the mitochondria, including cy-
tochrome c [6]. Nonetheless, Bcl-2 is found not only in mito-
chondria, but is also localized around the nuclear envelope as
well as in the endoplasmic reticulum (ER) [7^11], suggesting
the existence of additional Bcl-2 functions. In fact, it has been
demonstrated that Bcl-2 decreases the free Ca2 concentration
within the ER lumen by increasing the Ca2 permeability of
the ER membrane [12]. Moreover, Bcl-2 expression increases
Ca2 leakage in the ER, thus triggering alterations in the
homeostasis of the Golgi apparatus [13].
In the nematode Caenorhabditis elegans, one of these addi-
tional functions has been characterized for CED-9 (the Bcl-2
homologue); when overexpressed, this molecule sequesters
CED-4 (the Apaf-1 homologue) in insoluble subcellular frac-
tions [14]. In mammalian cells, however, no similar function
has been identi¢ed. Here we report that Bcl-2 regulates the
subcellular localization of Apaf-1, illustrated using WEHI-231
and CEM-C7-H.2 lymphocytes as models. We observed that
Apaf-1 is localized in Golgi in lymphocytes that do not ex-
press Bcl-2, whereas lymphocytes overexpressing Bcl-2 show
perinuclear Apaf-1 localization. Taken together, these data
indicate a new Bcl-2 function in mammalian cells that appears
similar to that observed for CED-9 in C. elegans.
2. Materials and methods
2.1. Cell culture
Wild type WEHI-231 and WEHI-231 cells expressing human Bcl-2
(hBcl-2) [15] were cultured in RPMI 1640 medium (BioWhittaker,
Walkersville, MD, USA) supplemented with 10% heat-inactivated
fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin, 100
Wg/ml streptomycin, 10 mM HEPES and 50 WM 2-mercaptoethanol
(Sigma, St. Louis, MO, USA). NIH-3T3 ¢broblasts were cultured in
Dulbecco’s modi¢ed Eagle medium supplemented with 10% FCS and
antibiotics as above; both were maintained at 37‡C in a humidi¢ed
5% CO2 atmosphere.
2.2. Production and characterization of polyclonal antibodies
Polyclonal anti-Apaf-1 antibody was generated in outbred New
Zealand rabbits using a peptide corresponding to the CED-4 domain.
The peptide, covering the human APAF-1 sequence 454^469
(QRYHQPHTLSPDQEDC), was synthesized using solid-phase pro-
cedure and standard Fmoc chemistry; a C-terminal Cys was included
for coupling purposes. The peptide was puri¢ed in reverse-phase high
performance liquid chromatography (HPLC); purity and composition
were con¢rmed by reverse-phase HPLC and amino acid analysis. For
immunization, the peptide was coupled to keyhole limpet hemocyanin
(Pierce, Rockford, IL, USA) via the C-terminal Cys. Puri¢ed IgG was
used for a⁄nity puri¢cation. Antibody speci¢city was con¢rmed by
immuno£uorescence in COS cells (Fig. 2), which do no express Apaf-1
protein [16].
2.3. Antibodies and reagents
Antibodies against hBcl-2 (clone 6C8) and mouse Bcl-2 (clone
3F11) were purchased from Pharmingen (San Diego, CA, USA).
Anti-protein disul¢de isomerase (PDI) antibody (clone 1D3) was pur-
chased from Stressgen (Victoria, BC, Canada). Texas red-conjugated
wheat germ agglutinin was purchased from Molecular Probes (Eu-
gene, OR, USA). Anti-L-coat protein (L-COP; clone M3A51) was
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from Sigma. Anti-Q-adaptin was purchased from Transduction (Lex-
ington, KY, USA).
2.4. Immuno£uorescence and image acquisition
For immuno£uorescence, cells were cultured in chamber slides,
washed in phosphate-bu¡ered saline (PBS), ¢xed in 4% paraformal-
dehyde (15 min, room temperature), pre-incubated in 2% bovine se-
rum albumin (BSA), and incubated for 1 h with primary antibody in
PBS containing 0.5% BSA and 0.1% Triton X-100. Cells were washed
three times in the same bu¡er and incubated for 1 h with Cy2- or Cy3-
conjugated secondary antibodies (Jackson ImmunoResearch, West
Grove, PA, USA). After washing, samples were incubated with TOP-
RO-3 (Molecular Probes) in PBS for DNA staining. Serial Z-sections
were obtained using an Ar^Kr laser and a TCS-NT Leica confocal
imaging system equipped with a 63U1.4 oil PLAPO objective. Cy2
was analyzed at 488 nm, Cy3 at 568 nm, and TOPRO-3 at 647 nm.
Images for each channel were captured separately and assembled into
a single ¢le with TCSMERGE software (Leica Microsystems, Heidel-
berg, Germany) prior to analysis. All confocal images were analyzed
using the Leica Vista+ (Beta Release 2) program. Images were pro-
cessed digitally using Adobe Photoshop (Adobe Systems, Inc.). All the
images in the ¢gures represent single sections.
3. Results
CED-9 is the Bcl-2 homologue in the nematode C. elegans ;
when overexpressed, this molecule sequesters CED-4 (the
Apaf-1 homologue) in insoluble subcellular fractions [14].
We analyzed Bcl-2 and Apaf-1 localization to study whether
Bcl-2 has a similar function in mammalian cells. The cytosolic
localization of Apaf-1 has recently been described [16]. To
extend the study of Apaf-1 compartmentalization, Apaf-1
subcellular localization was examined by confocal analysis
in NIH-3T3 ¢broblasts. We analyzed Apaf-1 co-localization
with the pyruvate dehydrogenase complex in mitochondria
[17], and PDI protein in ER [18], which indicated that
Apaf-1 did not co-localize in mitochondria or ER (Fig.
1A,B), con¢rming previous studies [16]. In contrast, co-local-
ization analysis with distinct Golgi markers showed Apaf-1 in
the Golgi apparatus (Fig. 1C^F). This observation was vali-
dated by co-localization with (1) wheat germ agglutinin, which
binds saccharide moieties in Golgi [19] (Fig. 1C,D), (2) L-COP
protein, which is found in Golgi and Golgi-derived (non-
clathrin) coated vesicles (Fig. 1E) [20], and (3) Q-adaptin pro-
tein in the cytoplasmic face of Golgi and Golgi clathrin-
coated vesicles (Fig. 1F) [21]. As a negative control, we ana-
lyzed endogenous Bcl-2 in the Golgi apparatus (Fig. 1G). This
indicates that, in addition to its cytosolic localization, Apaf-1
is also found in Golgi.
To con¢rm the immuno£uorescence analysis, we overex-
pressed Apaf-1 in COS cells, which lack the Apaf-1 protein
[16]. Apaf-1 overexpression was detected in these cells and
clearly expressed in cytoplasm and Golgi in the transfected
cells, compared to complete lack of expression in non-trans-
fected COS cells (Fig. 2). These results con¢rm the antibody
speci¢city, and reinforce the Apaf-1 localization in Golgi in
NIH-3T3 cells.
When overexpressed, CED-9 disrupts CED-4 localization in
C. elegans [14]. To study whether Bcl-2 alters Apaf-1 local-
ization in mammalian cells, we analyzed subcellular Apaf-1
distribution in the immature murine B cell lymphoma
WEHI-231 (WEHI-231/wt), as well as in stable WEHI-231
transfectants expressing hBcl-2 (WEHI-231/hBcl-2), which
are resistant to apoptosis [15]. In WEHI-231/wt cells, Apaf-1
staining shows a marked structure (Fig. 3A), whereas it sur-
rounds DNA in WEHI-231/hBcl-2 cells, acquiring a perinu-
clear localization (Fig. 3B). In NIH-3T3 ¢broblasts, however,
no similar Apaf-1 redistribution is detected when Bcl-2 is
overexpressed (Fig. 3C). These results indicate that Bcl-2
strongly disrupts Apaf-1 localization in WEHI-231, but not
in NIH-3T3 cells.
To examine the mechanism of Bcl-2-induced Apaf-1 redis-
tribution, we studied Apaf-1 localization in the Golgi appara-
tus. Apaf-1 clearly localized in Golgi in WEHI-231/wt cells
(Fig. 4A), whereas Apaf-1 disappears from Golgi in stable
WEHI-231/hBcl-2 transfectants (Fig. 4B). Furthermore, anal-
ysis of Apaf-1 and mitochondria indicated that Apaf-1 was
not found in mitochondria in either cell type (Fig. 4C,D).
Apaf-1 redistribution cannot be explained by interaction be-
tween Bcl-2 and Apaf-1, since they did not co-localize in im-
muno£uorescence microscopy (Fig. 4E). The data also indi-
cate that Apaf-1 does not redistribute from Golgi to
mitochondria or ER (not shown), where Bcl-2 is localized
[7^11], but rather redistributes to the perinuclear space.
Fig. 1. Apaf-1 localization in NIH-3T3 ¢broblasts. A: Immuno£uorescence analysis for Apaf-1 and mitochondria. Cells were treated as de-
scribed (Section 2). NIH-3T3 ¢broblasts were incubated with rabbit anti-Apaf-1 (green £uorescence) and human anti-mitochondrial antibody
(red). After incubation, samples were washed, then incubated with Cy2-conjugated anti-rabbit and Cy3-anti-human secondary antibodies.
B: Immuno£uorescence analysis for Apaf-1 and ER. NIH-3T3 ¢broblasts were incubated with rabbit anti-Apaf-1 (green) and anti-PDI anti-
body (red). After incubation, samples were washed, then incubated with Cy2-conjugated anti-rabbit and Cy3-anti-mouse secondary antibodies.
C: Immuno£uorescence analysis for Apaf-1 and Golgi. Cells were incubated with anti-Apaf-1 (green) and Texas red-conjugated wheat germ ag-
glutinin (WGA); Cy2-conjugated anti-rabbit antibody was used as second antibody. D: Detail of an NIH-3T3 ¢broblast stained for Apaf-1
(green) and Golgi (WGA, red). E: NIH-3T3 ¢broblast stained for Apaf-1 (green) and Golgi (L-COP, red); Cy2-anti-rabbit antibody and Cy3-
anti-mouse were used as second antibodies. F: NIH-3T3 ¢broblast stained for Apaf-1 (green) and Golgi (Q-adaptin, red); Cy2-anti-rabbit anti-
body and Cy3-anti-mouse were used as second antibodies. G: NIH-3T3 ¢broblast stained for Bcl-2 using anti-mouse Bcl-2 (clone 3F11, green)
and Golgi (WGA, red); Cy2-anti-rabbit antibody was used as second antibody. The TCS-NT Leica confocal imaging system was used,
equipped with a 63U1.4 oil PLAPO objective. Cy2 was analyzed at 488 nm and Cy3/Texas red at 568 nm. Images for each channel were cap-
tured separately and assembled into a single ¢le with TCSMERGE software prior to analysis. Confocal images were analyzed using the Leica
Vista+ (Beta Release 2) program. Images were processed digitally with Adobe Photoshop (Adobe Systems). The data are representative of the
total cell population.
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Fig. 2. Apaf-1 overexpression in COS cells. COS cells were transiently transfected with a clone of Apaf-1 (17) using FuGene 6 (Roche) accord-
ing to the manufacturer’s instructions. At 24 h after transfection, cells were ¢xed; immuno£uorescence analysis was performed (Section 2) to
detect Apaf-1 (K-530 antibody, green), Golgi (Q-adaptin, red) and DNA (TOPRO-3, blue). Cy2-anti-rabbit antibody and Cy3-anti-mouse were
used as secondary antibodies.
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4. Discussion
Here we show that Apaf-1 subcellular localization is cell
type-dependent and modi¢ed by Bcl-2 overexpression. In im-
muno£uorescence microscopy, we show that Bcl-2 induces
Apaf-1 redistribution from Golgi apparatus to perinuclear
compartments. This e¡ect of Apaf-1 re-localization is not
due to interaction between Apaf-1 and Bcl-2. A recent study
demonstrates that Apaf-1 does not interact with any Bcl-2
family member [22] ; this is supported by our immuno£uores-
cence analysis and yeast two-hybrid system experiments (not
shown). This suggests that Bcl-2 triggers Apaf-1 sequestration
indirectly, which may explain the cell type speci¢city of Apaf-
1 compartmentalization.
On the other hand, Bcl-2 is found in mitochondria, nuclear
envelope and ER [7^11]; in this last compartment, Bcl-2 de-
creases the free Ca2 concentration within the ER lumen by
increasing the Ca2 permeability of the ER membrane [12].
This Bcl-2 function provokes an increase in Ca2 leakage in
the ER, triggering alterations in the homeostasis of the Golgi
apparatus [13]. Alterations in the distribution of intracellular
calcium thus can disturb the mechanism that segregates secre-
tory from resident proteins in ER [23,24]. However, further
studies are needed to determine whether the relationship dem-
onstrated here between Apaf-1 and Bcl-2 has a role in in vivo
apoptosis.
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Fig. 3. Apaf-1 localization in WEHI-231/wt and WEHI-231/hBcl-2 cells. A: Immuno£uorescence for Apaf-1 and DNA in WEHI-231/wt cells.
Immuno£uorescence for Apaf-1 (green) using anti-Apaf-1 (K-530) and DNA staining (blue) using TOPRO-3. A detailed image of a cell is
shown. B: Immuno£uorescence for Apaf-1 and DNA in WEHI-231/hBcl-2 cells. Immuno£uorescence for Apaf-1 (green) and DNA staining
(blue). A detailed image is shown. C: Bcl-2 overexpression in NIH-3T3 ¢broblasts. Cells were transduced with a plasmid containing hBcl-2,
produced by cloning a retroviral vector (pCL-Bcl2-Neo) containing hBcl-2 cDNA into the EcoRI site of the pCLXSN retroviral plasmid. Ret-
roviral production was carried out by transient transfection of 293T cells. For viral transduction, 105 NIH-3T3 ¢broblasts were incubated over-
night with 5 Wg/ml of protamine sulfate (Sigma) in 1 ml of retroviral supernatant or alternatively, in virus-free medium. Infection was per-
formed at 37‡C and repeated 24 h later under the same conditions. Transduced NIH-3T3 ¢broblasts were treated, washed, ¢xed, pre-incubated
in BSA, and incubated with hamster anti-hBcl-2 (clone 6C8) and anti-Apaf-1 antibodies. After incubation, cells were washed and incubated
with Cy3-anti-hamster and Cy2-anti-rabbit secondary antibodies. After washing, optical sections were obtained. The data are representative of
the total cell population.
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Fig. 4. Apaf-1 localization in Golgi in WEHI-231/wt. A: Immuno£uorescence for Apaf-1 and Golgi. Apaf-1 (green) and Golgi stained with
Texas red-conjugated wheat germ agglutinin (red). A detail of a WEHI-231/wt cell is shown. B: Immuno£uorescence for Apaf-1 and Golgi in
WEHI-231/hBcl-2 cells. The arrow indicates the Golgi apparatus. Immuno£uorescence for Apaf-1 (red) and mitochondria (green) in WEHI-
231/wt (C), for Apaf-1 (red) and mitochondria (green) in WEHI-231/hBcl-2 cells (D), and for Apaf-1 (green) and hBcl-2 (red) in WEHI-231/
hBcl-2 cells (E). All samples were treated as described (Section 2). Images are representative of the entire population analyzed.
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